The company will begin commercialization of the IC-8 small aperture IOL, used for cataract patients, upon successful completion of the manufacturing facility inspections and receipt of an official approval order from the FDA, which the company estimates in Q2 2022.
Study shows statistically significant improvement for primary endpoint of bulbar conjunctival hyperemia for OTX-DED 0.2 mg and 0.3 mg formulations compared with vehicle hydrogel insert.
Successful treatment options can offer hope for patients with inherited disease.
Approaches include anti-vascular endothelial growth factor agents, fine needle diathermy, and corneal collagen crosslinking.
New acrylic implant provides option for patients with endothelial dysfunction.
In a presentation at the American Academy of Ophthalmology’s 2021 annual meeting in New Orleans, Nathan Hall pointed out that an epidemiologic analysis of malignant ocular surface tumours found significant differences in geographic prevalence rates in the United States.
Shady Awwad, MD, discusses how the application of mitomycin C after corneal crosslinking does not prevent development of corneal haze after the procedure and actually contributes to development of more corneal haze.
Dr Shady Awwad in a presentation at the American Academy of Ophthalmology’s 2021 annual meeting in New Orleans, pointed out that the application of mitomycin C after corneal crosslinking does not prevent development of corneal haze after the procedure and instead contributes to development of more corneal haze.
Procedure transfers intact donor nerve fibers to the cornea.
New serological biomarkers could characterise Sjögren’s syndrome better than traditionally used autoantibodies.
Results from Aurion Biotech's IOTA trial reveals that a corneal endothelial cell therapy showed improvements in visual acuity and central corneal thickness, according to a team of Japanese investigators.
Cynthia Matossian, MD, FACS, ABES, takes a look at the recent, sudden change in low-payment reimbursement by Medicare Administrative Contractors for LipFlow and MGD procedure codes.
Investigators sought to develop a severity scale for tomographic edema in FECD based on Scheimpflug tomography maps, and to evaluate intra- and inter-observer variation for assessing severity.
A cross sectional study investigated how chronic pain conditions outside of the eye impact corneal sensitivity.
A team of investigators at the Texas Tech University Health Sciences Center have developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.
Ex vivo experiment identifies potential benefit for supplementary oxygen.
Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.
Exploring subtleties helps ophthalmologists understand postoperative surprises.
A study sought to implement and test a trained deep learning algorithm using pre-operative corneal topography scans in order to classify between keratoconus and normal corneas, stage the disease, and predict whether a patient will be likely to benefit from CXL treatment.
A retrospective review was performed to describe changes in corneal thickness and to identify the incidence of posterior corneal changes characteristic of keratoconus, following DMEK surgery. Here’s what investigators found.
Mutations in this glaucoma-associated gene may be commonly reported in many other neurodegenerative diseases.
Scanning laser ophthalmoscopy offers improved view of posterior segment.
Investigators examine usefulness in refractive surgery evaluations.
A 48-year-old male patient presented to an ophthalmic emergency department with what was described as progressive bilateral corneal melting 5 weeks after he received the first dose of a COVID-19 vaccine.
CXL is safe, effective to perform on younger population, study results show.
